YASMIN ANWAR: Open Payments
NPI 1588602247 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 48 payments from 12 companies in 2025. Trend: 2023 $1,518 · 2024 $1,963 · 2025 $1,200
Food & beverage: $1,009Education: $191
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $266 |
| Janssen Biotech, Inc. | 4 | $156 |
| GENZYME CORPORATION | 4 | $143 |
| Amgen Inc. | 10 | $143 |
| ABBVIE INC. | 6 | $108 |
| Galderma Laboratories, L.P. | 4 | $105 |
| LEO Pharma Inc. | 4 | $103 |
| Organon LLC | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| UCB, Inc. | 2 | $44 |
Products named: DUPIXENT, TREMFYA, OTEZLA, ADBRY, SKYRIZI, NEMLUVIO, COSENTYX, Bimzelx.
Industry payments across CA — which companies pay providers there.
